Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

NCT06608251 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT06608251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06608251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2024
Completion date
May 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelinopathy